U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 138

Tests names and labsConditionsGenes, analytes, and microbesMethods

Clariti 20/20

QDx Pathology Services, Inc.
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Clariti 20/20

Clariti Diagnostics Laboratories LLC
United States
1544
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Plus Panel

BioReference Health
United States
9777
  • C Sequence analysis of the entire coding region

OnkoRisk Hereditary Oncology Management Panel

BioReference Health
United States
4717
  • C Sequence analysis of the entire coding region

OnkoRisk Women's Hereditary Cancer Panel

BioReference Health
United States
3418
  • C Sequence analysis of the entire coding region

BRACAnalysis CDx™

Myriad Genetics, Inc.
United States
62
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region

Hereditary Colon and Endometrial Cancer-ColoNGS

GeneKor MSA
Greece
107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome

GeneKor MSA
Greece
75
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MVL Vision Panel

Molecular Vision Laboratory
United States
13581028
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

CTNNB1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PRKN - MLPA

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis

CDH1 - MLPA

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis

AKT1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PIK3CA - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
141
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PRKN - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer + RNA Panel

Invitae
United States
14363
  • D Deletion/duplication analysis

Invitae Common Hereditary Cancers + RNA Panel

Invitae
United States
11447
  • D Deletion/duplication analysis

Early-Onset High Myopia Panel

PreventionGenetics, part of Exact Sciences
United States
285137
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Neurodevelopmental Disorders Panel

Invitae
United States
404241
  • D Deletion/duplication analysis

Results: 1 to 20 of 138

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.